Chemo and Immuno-Therapeutic Options for Nonsmall Cell Lung Cancer Lung Cancer.
Surg Clin North Am
; 102(3): 493-498, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-35671769
ABSTRACT
Over the last decade, the use of immune checkpoint inhibitors (ICI) has dramatically changed the treatment paradigm and outcome of patients with nonsmall cell lung cancer (NSCLC) across all stages of the disease. In this review, we provide a concise history of the use of ICIs in the treatment of NSCLC and review discuss the data behind the different indications.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Neoplasias Pulmonares
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article